SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: john dixon who wrote (2757)12/4/1998 10:06:00 AM
From: Tim K  Read Replies (1) | Respond to of 3702
 
The Coulter deal would be sweet for Techniclone.
$41mil. cash upfront, although $7mil of it appears to be stock purchase. SBH pays for further development but royalties and profits are split 50%. $41mil is about 9% of their market cap., and has added about 9% to their share price.

I don't know if the same formula is transferrable to TCLN but with a market cap. of
~$70mil. it would add a bit to the share price.
Tim


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News